KOL Perspectives Views on initial Phase III data for etrolizumab in IBDSummaryThis KOL Insight briefing focuses on KOL views on etrolizumab Phase III data presented at UEGW 2017 in both Crohn's disease and UC.The briefing includes analysis of KOL opinion o...
↧